S5 Ep43: Dietrich Details Data and Future Research With Immunotherapy in Stage III NSCLC

OncLive® On Air - Podcast autorstwa OncLive® On Air

Podcast artwork

Dr. Dietrich discusses the latest developments with immunotherapy and targeted therapy in stage III non–small cell lung cancer.

Visit the podcast's native language site